CIK 0001739410 · <br>Emerging growth company
Rallybio Corp
Sign in to watch- Ticker
- RLYB
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 851083789
- Phone
- 203- 859-3820
- Business address
- 234 CHURCH STREET, SUITE 1020, NEW HAVEN, CT, 06510
- Former names
- Rallybio Holdings, LLC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $9,608
- in 1 filing
Net −$9,608. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-05-17 | Nash Christine A Director | Grant or award · Option (Right to Buy) | +15,490 | 15,490 | ||
| 2023-05-17 | Boudreau Helen M Director | Grant or award · Option (Right to Buy) | +15,490 | 15,490 | ||
| 2023-05-17 | Hopfner Robert Lorne Director | Grant or award · Option (Right to Buy) | +15,490 | 15,490 | ||
| 2023-05-17 | Soteropoulos Paula Director | Grant or award · Option (Right to Buy) | +15,490 | 15,490 | ||
| 2023-05-17 | Liu Hui Director | Grant or award · Option (Right to Buy) | +15,490 | 15,490 | ||
| 2023-05-17 | HUNT RONALD Director | Grant or award · Option (Right to Buy) | +15,490 | 15,490 | ||
| 2023-05-17 | Chung Wendy Director | Grant or award · Option (Right to Buy) | +12,353 | 12,353 | ||
| 2023-03-14 | Lieber Jonathan I See Remarks | Purchase | +5,000 | $5.21 | $26K | 5,000 |
| 2023-03-07 | PARMAR KUSH Director | Sale | −100,000 | $8.20 | $820K | 2,378,969 |
| 2023-03-07 | 5AM Partners V, LLC 10% owner | Sale | −100,000 | $8.20 | $820K | 2,378,969 |
| 2023-02-06 | Uden Stephen See Remarks | Grant or award · Option (Right to Buy) | +214,000 | 214,000 | ||
| 2023-02-06 | Ryder Steven Chief Medical Officer | Grant or award · Option (Right to Buy) | +119,000 | 119,000 | ||
| 2023-02-06 | MACKAY MARTIN Chief Executive Officer | Grant or award · Option (Right to Buy) | +214,000 | 214,000 | ||
| 2023-02-01 | Lieber Jonathan I See Remarks | Grant or award · Option (Right to Buy) | +240,000 | 240,000 | ||
| 2023-01-03 | Liu Hui Director | Grant or award · Option (Right to Buy) | +10,237 | 10,237 | ||
| 2023-01-03 | PARMAR KUSH Director | Grant or award · Option (Right to Buy) | +10,344 | 10,344 | ||
| 2023-01-03 | Chung Wendy Director | Grant or award · Option (Right to Buy) | +9,482 | 9,482 | ||
| 2023-01-03 | HUNT RONALD Director | Grant or award · Option (Right to Buy) | +11,099 | 11,099 | ||
| 2022-11-15 | VIKING GLOBAL INVESTORS LP 10% owner | Purchase · Pre-Funded Warrants to Purchase Common Stock | +3,333,388 | $6.00 | $20.0M | 3,333,388 |
| 2022-08-01 | Chung Wendy Director | Grant or award · Option (Right to Buy) | +26,880 | 26,880 |
Page 6 of 11 · 216 trades